Shuttle Pharmaceuticals Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on March 22, 2024, by Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation. The filing serves as a current report to announce a corporate update issued in connection with the company's Annual Report on Form 10-K for the fiscal year ended December 31, 2023.
Key Financial Metrics
The provided text does not contain specific financial data points such as revenue, profit, cash flow, margins, debt, or liquidity figures. The filing references a press release (Exhibit 99.1) for these details but does not include the numerical values within the body of this 8-K document.
Material Changes
No material changes to financial condition or operations are detailed in this specific filing text. The document acts as a notification of the release of the 2023 annual results rather than a standalone report of new operational changes.
Guidance, Outlook, and Risks
The filing incorporates a press release by reference but does not explicitly state guidance, outlook, or specific risk factors in the text provided. The document notes that the information contained in Item 2.02 and the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section unless specifically referenced in a subsequent filing.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release) for specific 2023 financial results and operational updates.
- Access the full Form 10-K for the year ended December 31, 2023, to verify detailed financial statements, cash flow, and liquidity positions.
- Confirm the company's status as an Emerging Growth Company and its election regarding extended transition periods for accounting standards.
- Verify the trading symbol SHPH on The Nasdaq Stock Market LLC for current market data.